EndeavorRx Insight® Hack 2.3.0 + Redeem Codes

Follow your child's in-game treatment journey with EndeavorRx Insight: the official EndeavorRx® companion app for parents.

This free app connects directly to your child’s EndeavorRx treatment, so you can get a daily snapshot of your child's in-game mission completion and effort score.

KEY FEATURES:

- VIEW MISSION COMPLETION — See if your child's completed all of their play for the day, so you can help them stay on track.

- MONITOR DAILY EFFORT — By analyzing in-game interactions, we calculate a daily score to give you a sense of your child's level of effort and if your child is playing correctly according to the rules.

- TRACK SYMPTOMS — By using the 21 question caregiver assessment.

- EXPORT REPORTS — Generate reports and share the results with your child’s health care provider to inform the conversation and treatment planning.

- GET SUPPORT — Having an issue? The app can help connect you to our Akili Assist® support team.

Important: In order to use EndeavorRx Insight, your child must already have an active prescription for the EndeavorRx digital treatment and be connected to the internet.

WHAT IS ENDEAVORRX?

EndeavorRx is the first & only FDA-authorized video game treatment for inattention for kids 8-12 with ADHD. Access to treatment in the game requires a prescription from your child's healthcare provider.

Created by world-class neuroscientists and award-winning game designers, EndeavorRx is powered by Selective Stimulus Management Engine (SSME™) technology that is designed to challenge and target areas of the brain that play a key role in attention function.

For more information, and to start a virtual appointment with a doctor or get tips on how to talk to your current doctor to determine if EndeavorRx may be right for your child, visit EndeavorRx.com.

INDICATIONS FOR USE

EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.

SIDE EFFECTS

No serious adverse events were reported. Of 538 participants in trials supporting EndeavorRx authorization, 50 participants (9.3%) experienced treatment-related adverse events (probable, likely), and three participants experienced treatment-related adverse events with the digital control, in studies where a control was used. Associated adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). All adverse events were generally transient. Only 3 events led to device discontinuation, and no subject reported lasting or irreversible effects after discontinuation.

Akili, EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, SSME, Play Your Medicine, and Akili Assist, as well as the logos for each, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks are trademarks or registered trademarks of their respective owners. Please see the Terms of Use below for applicable patent protection for EndeavorRx.

Terms of Use: https://my.akili.care/terms
Privacy Notice: https://my.akili.care/privacy